BAYN.DE Bayer AG N
Healthcare · Drug Manufacturers - General
49.01
+0.55%
About the company
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a Strategic Alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
52-week range
Dividend deep dive
Bayer AG N (BAYN.DE) is a German healthcare company operating in the Drug Manufacturers - General industry. Its current dividend yield of 0.23% is notably below its 5-year average of 2.71% and its 5-year high of 5.13%, indicating an overvalued status based on yield theory. The company's dividend safety is currently rated as at-risk, and it has a dividend streak of 0 years. The company's market capitalization is not available.
Dividend history
Bayer AG N has a dividend streak of 0 consecutive years of increases. Over the last three years, the dividend has decreased at a CAGR of -0.6197%, and over five years, it decreased at a CAGR of -0.4766%. Annual dividends per share have been: 2.0666 EUR (2014), 2.2142 EUR (2015), 2.4602 EUR (2016), 2.6571 EUR (2017), 2.7555 EUR (2018), 2.8 EUR (2019), 2.8 EUR (2020), 2.0 EUR (2021), 2.0 EUR (2022), 2.4 EUR (2023), and projected 0.11 EUR for both 2024 and 2025. Dividends are paid annually.
Dividend safety
The company's dividend safety is rated as at-risk. A current payout ratio is not available in the provided data, and FFO payout percentage is also not available as it is not a REIT.
Quantic · Free
Read the rest of the safety verdict
Plus the key risks and what to watch next — free, no card.
AI-generated from Quantic's dividend data · Updated 17 Jul 2026 · Information, not financial advice.
Price history
Dividend profile
Yield band A stock's current dividend yield shown against its own range over the past five years — the low, average and high. Near the high end the shares look relatively cheap for the income they pay; near the low end, relatively expensive. It's the picture behind Dividend Yield Theory. Learn more → (5-year)
Payment calendar
Dividend history
Per-share dividend by year
Debt & leverage
Latest reported balance-sheet figures.
Held by 1 investor · watched by 1
Appears in these lists
BAYN.DE qualifies for these curated dividend rankings.
New to dividend investing?
Information, not financial advice.
Quantic · Free
Track BAYN.DE and your whole portfolio
Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →